StreetAlpha.app
Home › Stocks › APYX

Apyx Medical Corp (APYX)

$2.56
▼ −3.58%
LAST CLOSE · NOV 17

Apyx Medical makes surgical devices used in cosmetic surgery and hospital operations. It last closed at $2.56 on Nov 17, down 3.58% on the day.

AI Auto Pilots
Is APYX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$59.6M
+24.4% vs a year ago
Net income
−$8.4M
−14.2% margin
EPS (diluted)
−$0.19
Free cash flow
−$8.9M
−14.9% margin
Valuation
Market cap
$107.6M
42.1M shares
P/E
–
No P/E while losing money
Price to sales
1.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$25.8M
At Sep 30
Debt
$37.5M
At Sep 30
Shareholder equity
$9.6M
Shares outstanding
42.1M
At Nov 4
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $48.5M$48.5MFY2021FY2022: $44.5M$44.5MFY2022FY2023: $52.3M$52.3MFY2023FY2024: $48.1M$48.1MFY2024FY2025: $52.8M$52.8MFY2025

From APYX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated APYX in the past 90 days, not enough for a consensus
Average 12-month target
$6.00
▲ 134.8% upside

Based on 1 analyst who set a price target on APYX in the past 90 days. The average target is $6.00, with a high of $6.00 and a low of $6.00, compared with the last close of $2.56.

Low $6.00Avg $6.00High $6.00
Blue marker: last close $2.56
Highest target$6.00
Average target$6.00
Lowest target$6.00
Latest rating changes
Maxim GroupInitiated
Sep 29Buy$6
HC Wainwright & Co.Initiated
Jul 13Buy$7
DateFirmActionRatingPrice target
Sep 29Maxim GroupInitiatedBuy$6
Jul 13HC Wainwright & Co.InitiatedBuy$7
Loading…

Technical Analysis

APYX · as of the Nov 17 close · updated after every close
Downtrend

The stock is 5% below its 20 day and 6% below its 50 day average. It is 38% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 43). The nearest support is the Pivot at $2.54, and the nearest resistance the swing high (Oct 6) at $2.63.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 8.0%/day
Key levels
$5.0852 week high+98.4%
$3.53200 day average+37.9%
$3.22100 day average+25.8%
$2.7150 day average+5.9%
$2.6920 day average+5.1%
$2.69Pivot R1+5.1%
$2.63Swing high (Oct 6)+2.7%
$2.56Last close
$2.54Pivot−0.8%
$2.40Pivot S1−6.3%
$2.34Swing low (Oct 8)−8.6%
$2.2552 week low−12.1%
Indicators
RSI (14)42.86Middle of its rangeNeutral
MACD0.03Below its signal lineBearish
Stochastic28.2Middle of its rangeNeutral
ADX (14)29.2Trending down
Williams %R-81.0Oversold below −80, overbought above −20Oversold
CCI (20)-52.3Oversold below −100, overbought above 100Neutral
Rate of change−1.7%Change over 10 sessionsBearish
ATR (14)$0.20Typical daily range, 8.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for APYX

What happened before

See how APYX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow APYX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How APYX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in APYX in the last 90 days.

Loading…

See today’s whale options flow across the market →

APYX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼22 buying vs 43 selling
  • ▼Held by funds -8.7 pts
  • ▼Funds holding -1
  • ▼Superinvestors: 0 added, 4 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding6970−1.4%
In funds' top 1001−100.0%
Held by funds49.9%58.6%−8.7 pts
New / increased11 / 1112 / 25−40.5%
Reduced / sold out31 / 1221 / 10+38.7%
Put/call ratio0.000.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See APYX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether APYX is in one of them and how their past APYX trades turned out.

APYX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered APYX in an article yet. Here's the latest on the wider market.

About Apyx Medical

Apyx Medical is a surgical device company based in Clearwater, Florida. It makes Renuvion and the AYON Body Contouring System for cosmetic surgeons, and J-Plasma for hospital surgery, using controlled heat delivered to tissue. The company also supplies its technology to other device makers under OEM agreements. Its products are sold through a direct sales force and international distributors.

Headquarters
Clearwater, FL